NCT04623138View on ClinicalTrials.gov

A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

CompletedOBSERVATIONAL
Enrollment

847

Participants

Timeline

Start Date

November 4, 2020

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
Covid19SARS-CoV Infection
Trial Locations (1)

94402

Evidation Health, San Mateo

Sponsors

Lead Sponsor

Evidation Health
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Vir Biotechnology, Inc.

INDUSTRY

collaborator

United States Department of Defense

FED

lead

Evidation Health

INDUSTRY

NCT04623138 - A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections | Biotech Hunter | Biotech Hunter